Abivax S.A. Adjustments For Increase Decrease In Trade Account Payable
Abivax S.A. (ABVX) reported Adjustments For Increase Decrease In Trade Account Payable of -EUR 6.21 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable · last filed 2026-03-23
- Abivax S.A. adjustments for increase decrease in trade account payable for the quarter ending 2025-12-31 was 8.05M EUR, a 4663.31% increase year-over-year.
- Abivax S.A. adjustments for increase decrease in trade account payable for the quarter ending 2025-09-30 was -28.00M EUR, a 304.87% decline year-over-year.
- Abivax S.A. adjustments for increase decrease in trade account payable for the quarter ending 2025-06-30 was 984.00K EUR.
- Abivax S.A. adjustments for increase decrease in trade account payable for the quarter ending 2025-03-31 was 12.75M EUR, a 145.32% increase year-over-year.
| Period end | Adjustments For Increase Decrease In Trade Account Payable 3 month | Adjustments For Increase Decrease In Trade Account Payable 6 month | Adjustments For Increase Decrease In Trade Account Payable 9 month | Adjustments For Increase Decrease In Trade Account Payable 12 month |
|---|---|---|---|---|
| 2025-12-31 | 8.05M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | -19.95M EUR derived: sum of 2 quarters · filed 2026-03-23 | -18.96M EUR derived: sum of 3 quarters · filed 2026-03-23 | -6.21M EUR 20-F · filed 2026-03-23 |
| 2025-09-30 | -28.00M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-12-15 | -27.01M EUR derived: sum of 2 quarters · filed 2025-12-15 | -14.26M EUR 6-K · filed 2025-12-15 | -14.09M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-06-30 | 984.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-09-08 | 13.74M EUR 6-K · filed 2025-09-08 | 13.91M EUR derived: sum of 3 quarters · filed 2026-03-23 | 27.57M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-03-31 | 12.75M EUR 6-K · filed 2025-06-02 | 12.92M EUR derived: sum of 2 quarters · filed 2026-03-23 | 26.59M EUR derived: sum of 3 quarters · filed 2026-03-23 | 4.11M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2024-12-31 | 169.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | 13.84M EUR derived: sum of 2 quarters · filed 2026-03-23 | -8.64M EUR derived: sum of 3 quarters · filed 2026-03-23 | -3.44M EUR 20-F · filed 2026-03-23 |
| 2024-09-30 | 13.67M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-12-15 | -8.81M EUR derived: sum of 2 quarters · filed 2025-12-15 | -3.61M EUR 6-K · filed 2025-12-15 | |
| 2024-06-30 | -22.48M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-09-08 | -17.28M EUR 6-K · filed 2025-09-08 | ||
| 2024-03-31 | 5.20M EUR 6-K · filed 2025-06-02 | |||
| 2023-12-31 | 31.76M EUR 20-F · filed 2026-03-23 | |||
| 2022-12-31 | -2.39M EUR 20-F · filed 2025-03-24 | |||
| 2021-12-31 | 1.14M EUR 20-F · filed 2024-04-05 |